Overall, our results point to a role of pyrogallol-O-sulfate in different stages of diabetic retinopathy progression by affecting the expression of pro-angiogenic VEGF in in vitro RPE cells and preventing microglia activation earlier after a single intraocular injection in diabetic mice models. The gene discussed is VEGFA; the disease is diabetic retinopathy.